Zanamivir (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zanamivir" in Romanian language version.

refsWebsite

Global rank Romanian rank

16nih.gov

4^th place

14doi.org

2^nd place

3^rd place

5fda.gov

447^th place

173^rd place

3web.archive.org

1^st place

2ebi.ac.uk

5,849^th place

138^th place

2cdc.gov

218^th place

97^th place

2csiro.au

4,114^th place

2,747^th place

1cas.org

8,332^nd place

310^th place

1chemspider.com

8,573^rd place

247^th place

1drugbank.com

low place

160^th place

1harvard.edu

18^th place

27^th place

1bond.edu.au

low place

1semanticscholar.org

11^th place

638^th place

1reuters.com

49^th place

124^th place

bond.edu.au (Global: low place; Romanian: low place)

pure.bond.edu.au

Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.

cas.org (Global: 8,332^nd place; Romanian: 310^th place)

commonchemistry.cas.org

CAS Common Chemistry, accesat în 8 aprilie 2021

cdc.gov (Global: 218^th place; Romanian: 97^th place)

„2008-2009 Influenza Season Week 32 ending August 15, 2009”. Flu Activity & Surveillance. Centers for Disease Control and Prevention (CDC). 21 august 2009.
„Influenza Antiviral Medications: Summary for Clinicians”. CDC. 11 mai 2018. Accesat în 21 aprilie 2014.

chemspider.com (Global: 8,573^rd place; Romanian: 247^th place)

Zanamivir (în engleză), Q2311683, accesat în 20 noiembrie 2016

csiro.au (Global: 4,114^th place; Romanian: 2,747^th place)

csiropedia.csiro.au

„Archived copy”. Arhivat din original la 4 octombrie 2013. Accesat în 2 octombrie 2013.
„Archived copy”. Arhivat din original la 5 octombrie 2013. Accesat în 2 octombrie 2013.

doi.org (Global: 2^nd place; Romanian: 3^rd place)

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.
Hu, Y.; Lu, S.; Song, Z.; Wang, W.; Hao, P.; Li, J.; Zhang, X.; Yen, H. L.; Shi, B. (2013). „Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance”. The Lancet. 381 (9885): 2273–2279. doi:10.1016/S0140-6736(13)61125-3. PMID 23726392.
Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.
Heneghan, CJ; Onakpoya, I; Thompson, M; Spencer, EA; Jones, M; Jefferson, T (9 d.Hr.). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ (Clinical Research Ed.). 348: g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Heneghan, C. J.; Onakpoya, I.; Thompson, M.; Spencer, E. A.; Jones, M.; Jefferson, T. (9 aprilie 2014). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ. 348 (apr09 2): g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Wang, K; Shun-Shin, M; Gill, P; Perera, R; Harnden, A (18 d.Hr.). „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database of Systematic Reviews. 4 (4): CD002744. doi:10.1002/14651858.CD002744.pub4. PMC 6599832 . PMID 22513907.
Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana (2011). „Systematic review of influenza resistance to the neuraminidase inhibitors”. BMC Infectious Diseases. 11 (1): 134. doi:10.1186/1471-2334-11-134. PMC 3123567 . PMID 21592407.
Hayden FG (decembrie 2001). „Perspectives on antiviral use during pandemic influenza”. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356 (1416): 1877–84. doi:10.1098/rstb.2001.1007. PMC 1088564 . PMID 11779387.
Freund, B; Gravenstein, S; Elliott, M; Miller, I (1999). „Zanamivir: a review of clinical safety”. Drug Safety. 21 (4): 267–81. doi:10.2165/00002018-199921040-00003. PMID 10514019.
Cyranoski D (septembrie 2005). „Threat of pandemic brings flu drug back to life”. Nature Medicine. 11 (9): 909. doi:10.1038/nm0905-909. PMID 16145557.
Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.
Varghese, J. N.; Laver, W. G.; Colman, P. M. (1983). „Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 a resolution”. Nature. 303 (5912): 35–40. doi:10.1038/303035a0. PMID 6843658.
„Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid”. Virology. 58 (2): 457–63. aprilie 1974. doi:10.1016/0042-6822(74)90080-4. PMID 4362431.
„Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus”. Nature Biotechnology. 27 (6): 510–3. iunie 2009. doi:10.1038/nbt0609-510. PMID 19513050.

drugbank.com (Global: low place; Romanian: 160^th place)

Zanamivir (în engleză), DrugBank, 17 noiembrie 2015

ebi.ac.uk (Global: 5,849^th place; Romanian: 138^th place)

Zanamivir (în engleză), ChEMBL, accesat în 19 ianuarie 2016
ZANAMIVIR (în engleză), ChEMBL, accesat în 20 noiembrie 2016

fda.gov (Global: 447^th place; Romanian: 173^rd place)

zanamivir (în engleză), Global Substance Registration System, accesat în 20 noiembrie 2016
„FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children FDA press release March 29, 2006”. FDA.
„FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children”. FDA press release.
„Safe and Appropriate Use of Influenza Drugs”. Public Health Advisories (Drugs). U.S. Food and Drug Administration (FDA). 30 aprilie 2009. Arhivat din original la 4 noiembrie 2009. Accesat în 11 noiembrie 2009.
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm186081.htm

harvard.edu (Global: 18^th place; Romanian: 27^th place)

adsabs.harvard.edu

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.

nih.gov (Global: 4^th place; Romanian: 4^th place)

ncbi.nlm.nih.gov

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.
Hu, Y.; Lu, S.; Song, Z.; Wang, W.; Hao, P.; Li, J.; Zhang, X.; Yen, H. L.; Shi, B. (2013). „Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance”. The Lancet. 381 (9885): 2273–2279. doi:10.1016/S0140-6736(13)61125-3. PMID 23726392.
Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.
Heneghan, CJ; Onakpoya, I; Thompson, M; Spencer, EA; Jones, M; Jefferson, T (9 d.Hr.). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ (Clinical Research Ed.). 348: g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Heneghan, C. J.; Onakpoya, I.; Thompson, M.; Spencer, E. A.; Jones, M.; Jefferson, T. (9 aprilie 2014). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ. 348 (apr09 2): g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Wang, K; Shun-Shin, M; Gill, P; Perera, R; Harnden, A (18 d.Hr.). „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database of Systematic Reviews. 4 (4): CD002744. doi:10.1002/14651858.CD002744.pub4. PMC 6599832 . PMID 22513907.
Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana (2011). „Systematic review of influenza resistance to the neuraminidase inhibitors”. BMC Infectious Diseases. 11 (1): 134. doi:10.1186/1471-2334-11-134. PMC 3123567 . PMID 21592407.
Hayden FG (decembrie 2001). „Perspectives on antiviral use during pandemic influenza”. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356 (1416): 1877–84. doi:10.1098/rstb.2001.1007. PMC 1088564 . PMID 11779387.
Freund, B; Gravenstein, S; Elliott, M; Miller, I (1999). „Zanamivir: a review of clinical safety”. Drug Safety. 21 (4): 267–81. doi:10.2165/00002018-199921040-00003. PMID 10514019.
Cyranoski D (septembrie 2005). „Threat of pandemic brings flu drug back to life”. Nature Medicine. 11 (9): 909. doi:10.1038/nm0905-909. PMID 16145557.
Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.
Varghese, J. N.; Laver, W. G.; Colman, P. M. (1983). „Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 a resolution”. Nature. 303 (5912): 35–40. doi:10.1038/303035a0. PMID 6843658.
„Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid”. Virology. 58 (2): 457–63. aprilie 1974. doi:10.1016/0042-6822(74)90080-4. PMID 4362431.
„Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus”. Nature Biotechnology. 27 (6): 510–3. iunie 2009. doi:10.1038/nbt0609-510. PMID 19513050.

pubchem.ncbi.nlm.nih.gov

„Zanamivir”, zanamivir (în engleză), PubChem, accesat în 20 noiembrie 2016
„Zanamivir”, zanamivir (în engleză), PubChem, accesat în 19 octombrie 2016

reuters.com (Global: 49^th place; Romanian: 124^th place)

Hirschler, Ben (19 ianuarie 2011). „GSK tests intravenous flu drug vs Roche's Tamiflu”. Reuters.

semanticscholar.org (Global: 11^th place; Romanian: 638^th place)

Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.

web.archive.org (Global: 1^st place; Romanian: 1^st place)

„Safe and Appropriate Use of Influenza Drugs”. Public Health Advisories (Drugs). U.S. Food and Drug Administration (FDA). 30 aprilie 2009. Arhivat din original la 4 noiembrie 2009. Accesat în 11 noiembrie 2009.
„Archived copy”. Arhivat din original la 4 octombrie 2013. Accesat în 2 octombrie 2013.
„Archived copy”. Arhivat din original la 5 octombrie 2013. Accesat în 2 octombrie 2013.

Zanamivir (Romanian Wikipedia)

bond.edu.au (Global: low place; Romanian: low place)

pure.bond.edu.au

cas.org (Global: 8,332nd place; Romanian: 310th place)

commonchemistry.cas.org

cdc.gov (Global: 218th place; Romanian: 97th place)

chemspider.com (Global: 8,573rd place; Romanian: 247th place)

csiro.au (Global: 4,114th place; Romanian: 2,747th place)

csiropedia.csiro.au

doi.org (Global: 2nd place; Romanian: 3rd place)

drugbank.com (Global: low place; Romanian: 160th place)

ebi.ac.uk (Global: 5,849th place; Romanian: 138th place)

fda.gov (Global: 447th place; Romanian: 173rd place)

harvard.edu (Global: 18th place; Romanian: 27th place)